December Press Conference

Transcription

1 December Press Conference Carl Zeiss Group Stuttgart, December 12, 2007 Dr. Dieter Kurz President & CEO Dr. Michael Kaschke CFO Carl Zeiss December Press Conference, Stuttgart, December 12,

2 Carl Zeiss Group: Dynamic Growth Continued in Fourth Consecutive Year in EUR million 2006/ /06 Change Incoming orders 2,704 2, % Sales revenues 2,604 2,433 Adjusted for currency influences: + 7% + 9% EbIT (Earnings before Interest and Taxes) % EVA (Economic Value Added) % 09/30/ /30/2006 Employees (headcount excl. trainees) 12,257 11, Carl Zeiss December Press Conference, Stuttgart, December 12,

3 Carl Zeiss Generates 83 Percent of Its Business Outside Germany Shares of total revenues in percent (September 30, 2007) Europe EUR 1,718 million Change over previous year: + 13% 66% incl. in Germany EUR 432 million +14% 17% Americas EUR 530 million +/- 0%* 20% 12% Others EUR 41 million + 15% 2% Asia EUR 315 million + 7%* * Adjusted for currency influences at previous year's exchange rates Carl Zeiss December Press Conference, Stuttgart, December 12,

4 Sales Revenues Reach an All-time High: EUR 2,604 million Medical and Research Solutions Industrial Solutions Lifestyle Products Medical Systems Microscopy Semiconductor Technology Industrial Metrology Consumer Optics/Optronics Carl Zeiss Vision (50% interest) 638m 323m 1,042m 316m 245m 844m + 1%* -5%* + 21%* + 14%* + 5%* + 5%** -1%** + 21%** + 16%** + 5%** + 3%** * Over previous year ** Adjusted for currency influences over previous year Carl Zeiss December Press Conference, Stuttgart, December 12,

5 Semiconductor Technology Group Sales revenues in EUR million 864 1, %* / / / / /07 HGB IFRS * Adjusted for currency influences EBIT: positive Employees (FTE) 2,040 1,981 1,977 2,199 2,496 Enabling the Nano-Age World 09/30/03 09/30/04 09/30/05 09/30/06 09/30/07 Carl Zeiss December Press Conference, Stuttgart, December 12,

6 Major Order from the USA Ivy League University Harvard Relies on Systems from Carl Zeiss Harvard University ordered a total of eight electron and ion microscope systems intended for use at the university's Center for Nanoscale Systems. The facility conducts globally leading basic research on the interdisciplinary field of nanotechnology. Carl Zeiss December Press Conference, Stuttgart, December 12,

7 Medical Systems Group Sales revenues** in EUR million %* 2002/ / / / /07 HGB IFRS Adjusted for currency influences EBIT: positive Employees (FTE) 1,674 1,802 2,177 2,274 2,467 Vision in Focus 09/30/03 09/30/04 09/30/05 09/30/06 09/30/07 ** Carl Zeiss Meditec AG and sales organizations Carl Zeiss December Press Conference, Stuttgart, December 12,

8 VisuMax: Non-contact Surgery Gentle treatment thanks to enhanced precision A small incision in the cornea a giant leap into a life without eyeglasses. The VisuMax femtosecond laser system permits these procedures to be performed without the aid of mechanical devices - providing even higher precision and safety, and causing less strain on the patient. Carl Zeiss December Press Conference, Stuttgart, December 12,

9 Microscopy Group Sales revenues in EUR million %* 2002/ / / / /07 HGB IFRS * Adjusted for currency influences EBIT: positive Employees (FTE) 1,562 1,534 1,617 1,562 1,758 Resolution to Succeed 09/30/03 09/30/04 09/30/05 09/30/06 09/30/07 Carl Zeiss December Press Conference, Stuttgart, December 12,

10 New Business Unit: Clinical Diagnostics Carl Zeiss strengthens its commitment to the field of clinical cancer research With the acquisition of the Clarient equipment business, Carl Zeiss is intensifying its commitment to the promising field of clinical cancer diagnostics and research. Clinical diagnostics support doctors in the diagnosis of diseases and in the selection of the appropriate therapy. With growing life expectancy in the population, clinical diagnostics are playing an increasingly important role. Carl Zeiss December Press Conference, Stuttgart, December 12,

11 Industrial Metrology Group Sales revenues in EUR million %* 2002/ / / / /07 HGB IFRS * Adjusted for currency influences EBIT: positive Employees (FTE) 1,305 1,323 1,260 1,286 1,509 Results you can trust 09/30/03 09/30/04 09/30/05 09/30/06 09/30/07 Carl Zeiss December Press Conference, Stuttgart, December 12,

12 Extended Portfolio Carl Zeiss Industrial Metrology acquires majority interest in Junker & Partner On October 1, Carl Zeiss Industrial Metrology acquired a 75 percent interest in Junker & Partner GmbH, thus systematically extending its portfolio. Junker & Partner specializes in the design, development and production of measuring equipment for the automotive and aircraft industries. Carl Zeiss December Press Conference, Stuttgart, December 12,

13 Consumer Optics/Optronics Group Sales revenues in EUR million %* 2002/ / / / /07 HGB IFRS * Adjusted for currency influences EBIT: positive Employees (FTE) ,357 1) 1,203 2) 1,504 3) 09/30/03 09/30/04 09/30/05 09/30/06 09/30/07 1) Incl. Sports Optics for the first time 2) Sale of Display Technology 3) Incl. DENEL Optronics, South Africa Visions for real Carl Zeiss December Press Conference, Stuttgart, December 12,

14 Successful in Hollywood Box office hit "Perfume" filmed with ZEISS Master Zoom lenses ZEISS Master Zoom is the latest high-performance zoom lens for major movie productions suitable for both analog and digital professional movie cameras. Its outstanding image quality and high speed set new standards in the field. Carl Zeiss December Press Conference, Stuttgart, December 12,

15 Carl Zeiss Vision Creates the Basis for Faster Growth Sales revenues of the Carl Zeiss Vision Group** in EUR million 789* %** * Pro forma revenues * Adjusted for currency influences EBIT: positive 2004/ / /07 Employees (FTE) 9,995 10,626 10,293 See the difference 09/30/05 09/30/06 09/30/07 ** Not consolidated in the financial statement of the Carl Zeiss Group Carl Zeiss December Press Conference, Stuttgart, December 12,

16 A New Chapter in the History of Eyeglass Lenses: i.scription A new experience in vision i.scription from Carl Zeiss Vision is a comprehensive concept, providing a new examination technique and an innovative process for the computation and production of eyeglass lenses optimized to the nearest 1/100th of a diopter. The computation of i.scription eyeglass lenses is based on the innovative i.profiler measuring system which analyzes the human eye with high precision and generates an individualized profile for every patient. Carl Zeiss December Press Conference, Stuttgart, December 12,

17 High Expenditure on Research and Development Strengthens Innovative Power EUR million 300 Carl Zeiss generates almost 60 percent of its revenues with products not older than five years %* 10% 10% 10% 11% / / / / /07 * % of revenues Carl Zeiss December Press Conference, Stuttgart, December 12,

18 Investment and Depreciation Continue at a High Level EUR million 120 Investment in property, plant and equipment Depreciation on property, plant and equipment / / / / /07 HGB IFRS Carl Zeiss December Press Conference, Stuttgart, December 12,

19 Another Substantial Rise in the Equity Ratio In % of the balance sheet total 30 30% % 15 19% 20% 17% /30/ /30/ /30/ /30/ /30/2007 HGB IFRS Carl Zeiss December Press Conference, Stuttgart, December 12,

20 Cash Flow* Reaches Record High EUR million % % 17% 100 9% 12% / / / / /07 * Before income taxes; calculated using the method recommended by the German Financial Analysis Association/Schmalenbach-Gesellschaft DVFA/SG Carl Zeiss December Press Conference, Stuttgart, December 12,

21 Net Liquid Assets Offer Scope for Further Growth EUR million * *) In 2006 und 2007, Carl Zeiss placed a total of EUR 305 million in a Contractual Trust Arrangement (CTA). In this way, Carl Zeiss has invested funds specifically to meet pension claims separately from operational business. The company s pension commitments remain unchanged. 0 09/30/ /30/ /30/ /30/ /30/2007 HGB IFRS Carl Zeiss December Press Conference, Stuttgart, December 12,

22 Trend Forecast for Fiscal Year 2007/08 Medical and Research Solutions Industrial Solutions Lifestyle Products Medical Systems Microscopy Semiconductor Technology Industrial Metrology Consumer Optics/Optronics (Carl Zeiss Meditec AG) Solutions for Ophthalmology (Carl Zeiss Surgical GmbH) Surgical Products (Carl Zeiss MicroImaging GmbH) Light Microscopy Laser Scanning Microscopes (Carl Zeiss SMT AG) Lithography Systems Process Control Systems (Carl Zeiss Industrielle Messtechnik GmbH) 3-D Metrology (Carl Zeiss Optronics GmbH) Optronics (Carl Zeiss AG) Still and Cine Camera Lenses (Carl Zeiss Jena GmbH) Planetariums (Carl Zeiss Sports Optics GmbH) Binoculars Spotting Scopes Riflescopes (Carl Zeiss Vision International GmbH) Valued at equity in consolidated operating result Eyeglass Products Carl Zeiss December Press Conference, Stuttgart, December 12,

23 Outlook: Carl Zeiss Continues to Focus on Growth Its success in the past few years provides Carl Zeiss with scope for futher expansion of its market position. The important key to growth is our innovative strength, backed by our strong brand and the ability to optimally meet the requirements of our customers in our role as a solution provider. Carl Zeiss started fiscal year 2007/2008 with the wind in its sails and is continuing its course to further growth despite the increasingly difficult economic climate. Carl Zeiss December Press Conference, Stuttgart, December 12,

24 Thank you very much for your attention Carl Zeiss December Press Conference, Stuttgart, December 12,

25 Carl Zeiss December Press Conference, Stuttgart, December 12,